Viromed Medical AG (XETRA:VME.DE)
| Market Cap | 119.00M+27.3% |
| Revenue (ttm) | 5.22M |
| Net Income | 342.07K |
| EPS | -0.01 |
| Shares Out | 21.25M |
| PE Ratio | n/a |
| Forward PE | 13.02 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 3,368 |
| Open | 5.85 |
| Previous Close | 5.75 |
| Day's Range | 5.60 - 5.85 |
| 52-Week Range | 2.60 - 8.45 |
| Beta | 1.67 |
| Analysts | Buy |
| Price Target | 11.00(+96.43%) |
| Earnings Date | n/a |
Viromed Medical AG has a live Insider Score.
Scored on 1 qualifying trade from 1 insider in the last 90 days.
About VME.DE
Viromed Medical AG engages in the development, manufacture, and distribution of medical products in Germany and internationally. The company offers ViroCAP, an application in dermatology and wound treatment; and PulmoPlas for the treatment of severe respiratory infections. It also provides non-prescription health products in the cosmetics, nutritional supplement, and medical and nursing supplies. The company was formerly known as Fonterelli SPAC2 AG. Viromed Medical AG was founded in 2021 and is based in Rellingen, Germany.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
$VME.DE stock is featured in our Insider Score Rankings, and Insider Trades datasets.
→ All Stock ListsRecently reported changes in VME.DE holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by VME.DE's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
VME.DE Estimated quarterly lobbying spending
Source: U.S. Senate LDA
U.S. Patents
New VME.DE patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to VME.DE from public contracts
Source: USAspending.gov
VME.DE Insider Score
Our composite score: insider buying, sector, volume, tone & dilution
Bull Case vs Bear Case
AI-generated from VME.DE’s recent data — informational, not investment advice
Insider Score
Our 0–100 Insider Score and the signals behind it.
The live Insider Score and its full factor breakdown are included with Insider Access.
Unlock Insider Score